| |
| |
|
| Insider
Information: |
Mitchell Dean J |
| Relationship: |
Director |
| City: |
Plainsboro |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
727,061 |
|
|
Indirect Shares
|
750 |
|
|
| Direct
Value |
$3,958,176 |
|
|
|
Indirect Value
|
$24,007 |
|
|
| Total
Shares |
727,811 |
|
|
| Total
Value |
$3,982,183 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 33.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
President, U.S. Primar... |
2003-09-10 |
60,000 |
2003-09-10 |
567 |
Premium* |
|
|
MGI Pharma Inc |
MOGN |
President, MGI, GP, In... |
2005-10-05 |
3,391 |
2005-10-05 |
183 |
Premium* |
|
|
ISTA Pharmaceuticals Inc |
ISTA |
Director |
2008-12-10 |
4,932 |
2007-10-11 |
0 |
Premium* |
|
|
Talecris Biotherapeutics Holding... |
TLCR |
Director |
2011-06-01 |
0 |
2010-04-01 |
0 |
Premium* |
|
|
Precigen Inc |
PGEN |
Director |
2024-03-14 |
503,183 |
|
0 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
|
2024-05-08 |
80,555 |
2015-04-22 |
0 |
Premium* |
|
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2015-11-17 |
0 |
Premium* |
|
|
Praxis Precision Medicines, Inc. |
PRAX |
Director |
2023-03-24 |
75,000 |
2023-03-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGEN |
Precigen Inc |
Director |
– • – |
2023-09-22 |
4 |
B |
$1.41 |
$35,250 |
D/D |
25,000 |
356,836 |
2.39 |
- |
|
| IMGN |
Immunogen Inc |
|
– • – |
2023-09-22 |
4 |
OE |
$14.70 |
$147,000 |
D/D |
10,000 |
152,667 |
0 |
- |
|
| IMGN |
Immunogen Inc |
|
– • – |
2023-09-22 |
4/A |
OE |
$14.70 |
$147,000 |
D/D |
10,000 |
103,000 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2024-02-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(103,000) |
0 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2024-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
106,837 |
463,673 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • – |
2024-03-14 |
4 |
A |
$1.43 |
$56,499 |
D/D |
39,510 |
503,183 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
|
– • – |
2024-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,537 |
80,555 |
0 |
- |
|
57 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
